Brooklyn ImmunoTherapeutics logo

Brooklyn ImmunoTherapeutics

ID: 5314681

Biopharmaceutical company focused on exploring effects of cytokine based therapies on cancer.

2

Funding Rounds

$33.2m

Money raised

Overview

Biopharmaceutical company focused on exploring effects of cytokine based therapies on cancer.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding series

Funding Series Analysis

The company Brooklyn ImmunoTherapeutics has raised a total of $12m in funding over 2 rounds.

Key Insights:

  • Brooklyn ImmunoTherapeutics Funding Round, March 2022: $12m
  • Brooklyn ImmunoTherapeutics Venture Funding Round November 2018: $21.2m